Intestinal bacteria consortium
Assets acting on this target.
- Class
- Oral live biotherapeutic product
- Notes
- audit finding #882 (minor); source: https://clinicaltrials.gov/api/v2/studies/NCT05003804
Related mechanisms
Assets acting on this target.
Related mechanisms
1 of 1 assets